These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6687572)

  • 1. Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.
    Bessin P; Bonnet J; Apffel D; Soulard C; Desgroux L; Pelas I; Benveniste J
    Eur J Pharmacol; 1983 Jan; 86(3-4):403-13. PubMed ID: 6687572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
    Filep JG; Braquet P; Mózes T
    Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs.
    Fiedler VB; Mardin M; Abram TS
    Basic Res Cardiol; 1987; 82(2):197-208. PubMed ID: 3606544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory effects of PAF-acether in newborn piglets.
    Bradley LM; Goldstein RE; Feuerstein G; Czaja JF
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H205-12. PubMed ID: 2912183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
    Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
    Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAF-acether and leukotriene participation in acute circulatory shock.
    Bessin P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():139-50. PubMed ID: 3774841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
    Squadrito F; Sturniolo R; Altavilla D; Santoro G; Campo GM; Arena A; Caputi AP
    Eur J Pharmacol; 1991 Jan; 192(1):47-53. PubMed ID: 2040364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats.
    Tarayre JP; Delhon A; Bruniquel F; Puech L; Tisne-Versailles J; Couzinier JP
    Eur J Pharmacol; 1986 May; 124(3):317-23. PubMed ID: 3755401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of platelet activating factor antagonist (CV-3988) on 6-keto-PGF1 alpha and thromboxane B2 in dogs with experimental endotoxin-induced shock.
    Okano S; Tagawa M; Urakawa N
    J Vet Med Sci; 1995 Feb; 57(1):81-5. PubMed ID: 7756431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vascular response to platelet-activating factor in conscious sheep.
    Toyofuku T; Kobayashi T; Koyama S; Kusama S
    Am J Physiol; 1988 Sep; 255(3 Pt 2):H434-40. PubMed ID: 3414811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen.
    Robertson DN; Smith GM
    Eur J Pharmacol; 1986 Apr; 123(1):91-7. PubMed ID: 3709663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological mechanisms of sudden death induced by platelet activating factor.
    Lefer AM; Müller HF; Smith JB
    Br J Pharmacol; 1984 Sep; 83(1):125-30. PubMed ID: 6435705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF1 alpha, and leukotriene C4 immunoreactivity in the intact domestic pig heart.
    Ezra D; Feuerstein G; Ramwell PW; Hayes E; Goldstein RE
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():19-21. PubMed ID: 3159202
    [No Abstract]   [Full Text] [Related]  

  • 14. Time course of various inflammatory mediators during recurrent endotoxemia.
    Klosterhalfen B; Hörstmann-Jungemann K; Vogel P; Flohé S; Offner F; Kirkpatrick CJ; Heinrich PC
    Biochem Pharmacol; 1992 May; 43(10):2103-9. PubMed ID: 1599496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
    Becker K; Förster W
    Biomed Biochim Acta; 1988; 47(10-11):S169-72. PubMed ID: 3248104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock.
    Mózes T; Braquet P; Filep J
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R872-7. PubMed ID: 2802004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations.
    Benveniste J; Boullet C; Brink C; Labat C
    Br J Pharmacol; 1983 Sep; 80(1):81-3. PubMed ID: 6652376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular reactions and respiratory events during platelet activating factor-induced shock.
    Felix SB; Baumann G; Raschke P; Maus C; Berdel WE
    Basic Res Cardiol; 1990; 85(3):217-26. PubMed ID: 2383216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog.
    Prosdocimi M; Finesso M; Gorio A; Languino LR; Del Maschio A; Castagnoli MN; De Gaetano G; Dejana E
    Am J Physiol; 1985 Apr; 248(4 Pt 2):H493-9. PubMed ID: 3838623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.